Dr. Reddy's Laboratories
157 hedge funds and large institutions have $1.39B invested in Dr. Reddy's Laboratories in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 61 reducing their positions, and 17 closing their positions.
334% more call options, than puts
Call options by funds: $694K | Put options by funds: $160K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12% more capital invested
Capital invested by funds: $1.24B → $1.39B (+$153M)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
1.03% less ownership
Funds ownership: 79.73% → 78.7% (-1%)
2% less funds holding
Funds holding: 160 → 157 (-3)
25% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$20.7M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.43M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.02M |
| 5 |
Renaissance Technologies
New York
|
+$4.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
BlackRock Group
London,
United Kingdom
|
-$20.8M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$13.2M |
| 3 |
OAM
Origin Asset Management
London,
United Kingdom
|
-$10.1M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$5.8M |
| 5 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
-$5.65M |
RDY Hedge Fund Activity: Q2 2016 in Review
157 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2016, worth a combined $1.39B — up 12% from $1.24B a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of RDY and 16 opened new positions — a net loss of 1 holder — while 61 trimmed existing stakes and 46 added.
The largest buyer was Fisher Asset Management, adding an estimated $20.7M. The largest seller was BlackRock Group, cutting an estimated $20.8M.
- 157 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2016, down from 160 in Q1 2016.
- Funds reported $1.39B of Dr. Reddy's Laboratories stock for Q2 2016, up 12% quarter-over-quarter.
- 16 funds opened new Dr. Reddy's Laboratories positions in Q2 2016 and 17 closed out, a net change of -1 holder.
- The largest Dr. Reddy's Laboratories buyer in Q2 2016 was Fisher Asset Management, an estimated $20.7M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2016 was BlackRock Group, an estimated $20.8M sold.
Based on aggregated 13F filings for Q2 2016.